HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 11 June 2012

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  33 papers were listed this time. Here's a few in our areas of research interest:

Lee S, Baxter DC, Limone B, et al. Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States. J Med Econ. 2012 May 14. [Epub ahead of print] PubMed PMID: 22583065.

Smith-Palmer J, Fajardo-Montañana C, Pollock RF, et al. Long-term cost-effectiveness of insulin detemir versus NPH insulin in type 2 diabetes in Sweden. J Med Econ. 2012 May 8. [Epub ahead of print] PubMed PMID: 22563742.